Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Awad, A. George
1993.
Methodological and Design Issues in Clinical Trials of New Neuroleptics: an Overview.
British Journal of Psychiatry,
Vol. 163,
Issue. S22,
p.
51.
Awad, A. G.
and
Hogan, T. P.
1994.
Subjective response to neuroleptics and the quality of life: implications for treatment outcome.
Acta Psychiatrica Scandinavica,
Vol. 89,
Issue. s380,
p.
27.
Fleischhacker, W. W.
1994.
Prediction of Neuroleptic Treatment Outcome in Schizophrenia.
p.
79.
Awad, A. G.
1994.
Prediction of Neuroleptic Treatment Outcome in Schizophrenia.
p.
1.
1995.
Book Reviews.
Journal of Psychiatric and Mental Health Nursing,
Vol. 2,
Issue. 6,
p.
373.
Bröker, Matthias
Röhricht, Frank
and
Priebe, Stefan
1995.
Initial assessment of hospital treatment by patients with paranoid schizophrenia: A predictor of outcome.
Psychiatry Research,
Vol. 58,
Issue. 1,
p.
77.
Hamera, Edna K.
Kraenzle Schneider, Joanne
Potocky, Miriam
and
Casebeer, Mary Ann
1996.
Validity of self-administered symptom scales in clients with schizophrenia and schizoaffective disorders.
Schizophrenia Research,
Vol. 19,
Issue. 2-3,
p.
213.
Heinrichs, R.Walter
Ruttan, Lesley
Zakzanis, Konstantine K.
and
Case, Danielle
1997.
Parsing Schizophrenia with Neurocognitive Tests: Evidence of Stability and Validity.
Brain and Cognition,
Vol. 35,
Issue. 2,
p.
207.
Garavan, J
Browne, S
Gervin, M
Lane, A
Larkin, C
and
O'Callaghan, E
1998.
Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight.
Comprehensive Psychiatry,
Vol. 39,
Issue. 4,
p.
215.
Mason, Susan E.
Bermanzohn, Paul C.
and
Siris, Samuel G.
1998.
Clinical Trials and Tribulations: Implementation Processes in Schizophrenia Research Outcome.
Psychiatry,
Vol. 61,
Issue. 4,
p.
288.
BROWNE, STEPHEN
GARAVAN, JEANNE
GERVIN, MAURICE
ROE, MARK
LARKIN, CONAL
and
O'CALLAGHAN, EADBHARD
1998.
Quality of Life in Schizophrenia: Insight and Subjective Response to Neuroleptics.
The Journal of Nervous & Mental Disease,
Vol. 186,
Issue. 2,
p.
74.
Priebe, Stefan
and
Bröker, Matthias
1999.
Prediction of hospitalizations by schizophrenia patients assessment of treatment: an expanded study.
Journal of Psychiatric Research,
Vol. 33,
Issue. 2,
p.
113.
Bullinger-Naber, M.
and
Naber, D.
1999.
Psychiatrie der Gegenwart 2.
p.
235.
Gervin, M.
Browne, S.
Garavan, J.
Roe, M.
Larkin, C.
and
O'Callaghan, E.
1999.
Dysphoric subjective response to neuroleptics in schizophrenia: relationship to extrapyramidal side effects and symptomatology.
European Psychiatry,
Vol. 14,
Issue. 7,
p.
405.
Hellewell, J S E
Kalali, A H
Langham, S J
McKellar, J
and
Awad, A G
1999.
Patient satisfaction and acceptability of long-term treatment with quetiapine.
International Journal of Psychiatry in Clinical Practice,
Vol. 3,
Issue. 2,
p.
105.
Browne, Stephen
Larkin, Conall
and
O'Callaghan, Eadbhard
1999.
Outcome studies in schizophrenia.
Irish Journal of Psychological Medicine,
Vol. 16,
Issue. 4,
p.
140.
Voruganti, L
Cortese, L
Oyewumi, L
Cernovsky, Z
Zirul, S
and
Awad, A
2000.
Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life.
Schizophrenia Research,
Vol. 43,
Issue. 2-3,
p.
135.
Gervin, Maurice
and
Barnes, Thomas R.E.
2000.
Assessment of drug-related movement disorders in schizophrenia.
Advances in Psychiatric Treatment,
Vol. 6,
Issue. 5,
p.
332.
Gervin, M.
Browne, S.
Garavan, J.
Roe, M.
Larkin, C.
and
O'Callaghan, E.
2000.
Respuesta subjetiva disfórica a los neurolépticos en la esquizofrenia: relación con los efectos secundarios extrapiramidales y los síntomas.
European psychiatry (Ed. Española),
Vol. 7,
Issue. 3,
p.
181.
Ellenbroek, B.A.
and
Cools, A.R.
2000.
Animal models for the negative symptoms of schizophrenia.
Behavioural Pharmacology,
Vol. 11,
Issue. 3 & 4,
p.
223.